Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aeolus Pharmaceuticals Inc (OTCQB:AOLS)

0.205
Delayed Data
As of Feb 05
 -0.024 / -10.48%
Today’s Change
0.17
Today|||52-Week Range
0.43
-14.58%
Year-to-Date
No recent news for Aeolus Pharmaceuticals Inc.

Today’s Trading

Previous close0.23
Today’s open0.21
Day’s range0.20 - 0.21
Volume26,250
Average volume (3 months)22,399
Market cap$31.1M
Dividend yield--
Data as of 3:57pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-3,233.33%
Earnings growth (this year)+4,800.00%
Earnings growth (next 5 years)--
Revenue growth (last year)-67.70%
P/E ratio10.3
Price/Sales10.51
Price/Book--

Competitors

No competitors data available.

Financials

Last reporting dateDecember 18, 2015
EPS forecast (this quarter)$0.00
Annual revenue (last year)$3.1M
Annual profit (last year)-$2.6M
Net profit margin-84.47%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Financial Officer &
Secretary
David C. Cavalier
President &
Chief Executive Officer
John L. McManus
Corporate headquarters
Mission Viejo, California

Forecasts

Partner Offers